Evidence map›Paper›PMID 28461313›Full record

ArticleAntimicrobial agents and chemotherapy2017

Phenotypic and Molecular Evaluation of Echinocandin Susceptibility of Candida glabrata, Candida bracarensis, and Candida nivariensis Strains Isolated during 30 Years in Argentina.

Soraya Morales-López, Catiana Dudiuk, Walter Vivot, Wanda Szusz, Susana B Córdoba, Guillermo Garcia-Effron

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Current medical mycology · 2022
    Article
  3. Overview on the Infections Related to RarePathogens (Basel, Switzerland) · 2022
    Review
  4. Candidiasis byJournal of fungi (Basel, Switzerland) · 2021
    Article
  5. Review
  6. First Isolation of Candida nivariensis, an Emerging Fungal Pathogen, in Kuwait.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Germs · 2019
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Soraya Morales-LópezDepartamento de Micología, Instituto Nacional de Enfermedades Infecciosas Dr. Carlos G. Malbrán, Buenos Aires, Argentina.
Catiana DudiukLaboratorio de Micología y Diagnóstico Molecular, Cátedra de Parasitología y Micología, Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Santa Fe, Argentina.
Walter VivotDepartamento de Micología, Instituto Nacional de Enfermedades Infecciosas Dr. Carlos G. Malbrán, Buenos Aires, Argentina.
Wanda SzuszDepartamento de Micología, Instituto Nacional de Enfermedades Infecciosas Dr. Carlos G. Malbrán, Buenos Aires, Argentina.
Susana B CórdobaDepartamento de Micología, Instituto Nacional de Enfermedades Infecciosas Dr. Carlos G. Malbrán, Buenos Aires, Argentina.
Guillermo Garcia-EffronLaboratorio de Micología y Diagnóstico Molecular, Cátedra de Parasitología y Micología, Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Santa Fe, Argentina ggarcia@unl.edu.ar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The echinocandin susceptibilities of 122

Indexed as

Antifungal AgentsCandidaCandida glabrataCandidiasisDrug Resistance, FungalEchinocandinsMicrobial Sensitivity TestsMutationPolymerase Chain ReactionAntifungal AgentsEchinocandinsCandida bracarensisCandida glabrata species complexCandida nivariensisechinocandin resistancehot spot

Identifiers

PMID28461313
PMCPMC5487631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.